Ind-Swift Laboratories Limited — Others, 12-11-2024: Monitoring Agency Report

Ind-Swift Laboratories has provided a Monitoring Agency Report for the quarter ended September 30, 2024, concerning its preferential issue, which raised ₹314.60 crore. The report confirms that all proceeds from the issue have been utilized according to the disclosed objectives, with no deviations noted. Key expenditures include ₹46.09 crore allocated for general corporate purposes, including repayment of overdrafts. The company's strategic focus appears on business expansion and working capital needs, maintaining a positive cash flow with idle funds invested in fixed deposits. This update may reinforce investor confidence given the transparent utilization of funds.